Brian Byeoung Kim
Directeur Général chez BIOHAUS Co., Ltd.
Postes actifs de Brian Byeoung Kim
| Sociétés | Poste | Début |
|---|---|---|
BIOHAUS Co., Ltd.
 BIOHAUS Co., Ltd. Pharmaceuticals: MajorHealth Technology BIOHAUS Co., Ltd. engages in the development and manufacture of fucntional health and synthetic biology products. Its products include bio plastics and pulps and natural antibacterial wet tissues. The company was founded in August 2012 and is headquartered in Seongnam, South Korea. | Directeur Général | 01/01/2012 |
Anciens postes connus de Brian Byeoung Kim
| Sociétés | Poste | Fin |
|---|---|---|
| CELLTRION, INC. | Corporate Officer/Principal | 30/04/2012 |
| CELLTRION PHARM, INC. | Corporate Officer/Principal | - |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELLTRION PHARM, INC. | Health Technology |
| CELLTRION, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
BIOHAUS Co., Ltd.
BIOHAUS Co., Ltd. Pharmaceuticals: MajorHealth Technology BIOHAUS Co., Ltd. engages in the development and manufacture of fucntional health and synthetic biology products. Its products include bio plastics and pulps and natural antibacterial wet tissues. The company was founded in August 2012 and is headquartered in Seongnam, South Korea. | Health Technology |
